Dan Segal

Dan Segal brings over 25 years of wide-ranging science and global commercialization experience to the team. Previously, he was a co-founder of the neuroscience company Brain Resource (now renamed Total Brain), where he served as COO, CFO and Board member overseeing growth from start-up to post public listing. During his tenure, Brain Resource built one of the largest personalized medicine-focused brain databases and helped create the market for brain health SaaS solutions, selling services to Fortune 500 companies. Notably, he was instrumental in the origination and implementation of the landmark iSPOT-Depression and iSPOT-ADHD treatment prediction studies. Prior to Brain Resource, he was a highly ranked analyst and a Director in Equities Research at Citigroup. Dan has a BComm and MSc (physics) from the University of New South Wales.